For safety and efficacy in targeted abdominal MR Imaging

CMC Contrast

Driven to making better contrast agents

CMC Contrast AB is a Swedish research company founded in 2000. We believe the diagnostic process should be as smooth and efficient as possible, and we are dedicated to developing contrast agents that are convenient for patients and more efficient for healthcare professionals. CMC 001 is under development and is ready for clinical phase III. It has been patented, tested and developed through an open innovation network of industrial partners, academic partners and subcontractors, while project management, research, and business strategy remain in-house.

 
Read more about CMC 001

A oral contrast media

About CMC Contrast

100% owned and financed by professional venture capital companies specializing in life sciences and dedicated to contrast agents

Learn more
Medical background

CMC 001 delivers manganese orally, resulting in excellent liver enhancement in MRI.

Medical background
Benefits for your team

Using CMC 001 creates advantages for the staff, and saves time and cost.

More Benefits
CMC Contrast AB, Ideon, SE-223 70 Lund. Telephone +46 46 286 37 60. E-mail: info@cmc-contrast.se